“Low Dose (d1-5 7) Oral Etoposide Regimen in Intensively Treated Platinum-Resistant Epithelial Ovarian Cancer: The İzmir Oncology Group (IZOG) Study ”. 2021. Annals of Medical Research 27 (1): 0029-0033. http://annalsmedres.org/index.php/aomr/article/view/591.